Fundraising Fox
Unleash Immuno Oncolytics
St. Louis, US · Founded 2015 · Delaware corporation · 2 known investors
Find your way into Unleash Immuno Oncolytics
Sign up to see every warm intro you have to Unleash Immuno Oncolytics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Unleash Immuno Oncolytics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AM
Ariel MusleraNamed on SEC filing
RL
Ricardo Lisandro BrilNamed on SEC filing
DK
BC
Bolten CharlesNamed on SEC filing
Investors · 2
Also in the syndicate · 1
Oncolys BioPharma
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2018
▶$3MraisedFeb 2018 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ariel MusleraDirector
- Ricardo Lisandro BrilDirector
- Daniel KatzmanExecutive Officer, Director
- Bolten CharlesDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Unleash Immuno Oncolytics's investors?
- Unleash Immuno Oncolytics's investors include BioGenerator Ventures.
- How much funding has Unleash Immuno Oncolytics raised?
- Unleash Immuno Oncolytics has disclosed $3M raised across 1 round.
- Where is Unleash Immuno Oncolytics headquartered?
- Unleash Immuno Oncolytics is headquartered in St. Louis, US.